Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chongguang Chen

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2014
Identification and verification of proteins interacting with the kappa opioid receptor (KOPR)Chongguang Chen, Peng Huang, Lee-Yuan Liu-Chen
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2014
Detection of mu opioid receptor (MOPR) and its glycosylation in rat and mouse brains by western blot with anti-μC, an affinity-purified polyclonal anti-MOPR antibodyPeng Huang, Chongguang Chen, Lee-Yuan Liu-Chen
Life Sciences|February 24, 2007
Dynorphin peptides differentially regulate the human kappa opioid receptorYong Chen, Chongguang Chen, Lee-Yuan Liu-Chen
Biochemistry|August 23, 2007
N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathwayJian-Guo Li, Chongguang Chen, Lee-Yuan Liu-Chen
The Journal of Biological Chemistry|May 11, 2002
Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rateJian-Guo Li, Chongguang Chen, Lee-Yuan Liu-Chen
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2006
Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonistsYong Chen, Chongguang Chen, Yulin Wang, et al.
The Journal of Biological Chemistry|March 11, 2011
Effects of C-terminal modifications of GEC1 protein and gamma-aminobutyric acid type A (GABA(A)) receptor-associated protein (GABARAP), two microtubule-associated proteins, on kappa opioid receptor expressionChongguang Chen, Yulin Wang, Peng Huang, et al.
Handbook of Experimental Pharmacology|June 4, 2021
Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor SystemChongguang Chen, Melanie Widmann, Christoph Schwarzer, et al.
European Journal of Pharmacology|December 8, 2014
K303⁶·⁵⁸ in the μ opioid (MOP) receptor is important in conferring selectivity for covalent binding of β-funaltrexamine (β-FNA)Kelly M DiMattio, Chongguang Chen, Lei Shi, et al.
Neuropharmacology|November 5, 2021
Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effectsPeng Huang, Chongguang Chen, Danni Cao, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2014
Identification and verification of proteins interacting with the kappa opioid receptor (KOPR)Chongguang Chen, Peng Huang, Lee-Yuan Liu-Chen
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2014
Detection of mu opioid receptor (MOPR) and its glycosylation in rat and mouse brains by western blot with anti-μC, an affinity-purified polyclonal anti-MOPR antibodyPeng Huang, Chongguang Chen, Lee-Yuan Liu-Chen
Life Sciences|February 24, 2007
Dynorphin peptides differentially regulate the human kappa opioid receptorYong Chen, Chongguang Chen, Lee-Yuan Liu-Chen
Biochemistry|August 23, 2007
N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathwayJian-Guo Li, Chongguang Chen, Lee-Yuan Liu-Chen
The Journal of Biological Chemistry|May 11, 2002
Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rateJian-Guo Li, Chongguang Chen, Lee-Yuan Liu-Chen
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2006
Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonistsYong Chen, Chongguang Chen, Yulin Wang, et al.
The Journal of Biological Chemistry|March 11, 2011
Effects of C-terminal modifications of GEC1 protein and gamma-aminobutyric acid type A (GABA(A)) receptor-associated protein (GABARAP), two microtubule-associated proteins, on kappa opioid receptor expressionChongguang Chen, Yulin Wang, Peng Huang, et al.
Handbook of Experimental Pharmacology|June 4, 2021
Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor SystemChongguang Chen, Melanie Widmann, Christoph Schwarzer, et al.
European Journal of Pharmacology|December 8, 2014
K303⁶·⁵⁸ in the μ opioid (MOP) receptor is important in conferring selectivity for covalent binding of β-funaltrexamine (β-FNA)Kelly M DiMattio, Chongguang Chen, Lei Shi, et al.
Neuropharmacology|November 5, 2021
Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effectsPeng Huang, Chongguang Chen, Danni Cao, et al.
Pageof 5